Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

ZymoGenetics/Novo Nordisk isolate anticlotting agent

Feb. 14, 1997

EPO activators/agonists described by J&J and Affymax

Feb. 14, 1997

Neutrophil-stimulating peptides derived from TNF described by Peptech

Feb. 13, 1997

Pfizer claims 5-LO inhibitors

Feb. 13, 1997

Sugen reports modulators of tyrosine signal transduction

Feb. 13, 1997

Anticancer agents from Takeda

Feb. 13, 1997

Novel antiarrhythmic agents described by Merck & Co.

Feb. 13, 1997

AGE inhibitors reported by Kissei

Feb. 13, 1997

Sulfonamide derivatives for inhibition of cell adhesion

Feb. 12, 1997

American Home Products describes antiproliferative agents

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...